Skip to main content

Table 2 Distribution of immunostaining intensity of peroxiredoxins in astrocytic tumor samples.

From: Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors

Intensity of immunostaining/peroxiredoxin Negative Weak Moderate Strong Prx- group/
Prx+ group
Prx I 32% 47% 18% 3% 79%/21%
Prx II 16% 32% 30% 22% 48%/52%
Prx III 10% 31% 39% 20% 41%/59%
Prx IV 95% 5% < 1% - 100%/-
Prx V 96% 4% - - 100%/-
Prx VI 53% 36% 10% 1% 89%/11%
  1. For the analyses, the four categories are further divided into two groups: The Prx negative group (Prx-) contains negatively and weakly stained tumors and Prx positive group (Prx+) contains tumors showing moderate or strong immunostaining.